UPDATE: JPMorgan Upgrades Atara Biotherapeutics (ATRA) to Overweight
Tweet Send to a Friend
(Updated - May 13, 2021 4:46 AM EDT)
JPMorgan analyst Anupam Rama upgraded Atara Biotherapeutics (NASDAQ: ATRA) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Anupam Rama upgraded Atara Biotherapeutics (NASDAQ: ATRA) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
